Inside the Semaglutide mechanism of action
Dear reader,
The interesting thing about semaglutide isn't just the signal it sends. It's how long that signal lasts. A gut hormone that fades in minutes and a medicine that stays around for weeks raise different questions at an appointment.
First, the receiver
Semaglutide acts like GLP-1, a hormone involved in blood sugar and appetite. It activates the GLP-1 receptor, a receiver on a cell. That's what “receptor agonist” means when you see it in a description of the medicine.
The Wegovy (semaglutide injection and tablets) prescribing information explains this shared target. Semaglutide is an altered copy of the natural hormone. Those changes help it stay in the body much longer.
The everyday explanation follows what that signal means for blood sugar, appetite and the stomach. Here, I'd focus on the timing. It's useful context for a conversation about side effects or a change in treatment.
A week is a halfway point
Semaglutide's “half-life” is about a week. Elimination half-life means the time it takes the medicine's concentration in the blood to fall by roughly half as the body clears it. It doesn't mean the medicine has disappeared a week later.
The Wegovy (semaglutide) label says it remains in circulation for about five to seven weeks after the last injectable dose. I'd keep “after the last injection” attached to that finding. It's easy to lose the meaning when a number travels without its context.
That long stay is one reason pregnancy plans belong in the conversation. The label connects pregnancy planning with the medicine's long half-life. It doesn't give a general website enough information to work out someone's treatment plan.
A tablet has a different journey
A tablet and an injection may share an ingredient without delivering it in the same way. The pharmacology reference describes how little oral semaglutide reaches the blood. Oral means taken by mouth.
That helps explain why two milligram numbers can't be compared on their own. The product and the way it gets into the body matter. The dose letter keeps those details beside its study examples.
Knowing the mechanism has limits
The label says the exact mechanism behind semaglutide's heart benefit hasn't been established. There's room to understand part of a medicine and still have questions about another part.
There are safety limits too. The same label warns about severe digestive reactions, pancreatitis—inflammation of the pancreas—and gallbladder problems. Knowing why a medicine lasts doesn't tell us whether it's a good fit for a particular person.
P.S. “Which part of this explanation changes our plan?” That's the detail I'd want to take home.